$DMTK Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in DermTech, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in DermTech, Inc.. Get notifications about new insider transactions in DermTech, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 28 2021 | DMTK | DermTech, Inc. | Picozza Enrico | Director | Sell | S | 40.08 | 20,297 | 813,577 | 500,000 | 520.3 K to 500 K (-3.90 %) |
May 28 2021 | DMTK | DermTech, Inc. | Picozza Enrico | Director | Grant | A | 0.00 | 4,661 | 0 | 23,158 | 18.5 K to 23.2 K (+25.20 %) |
May 28 2021 | DMTK | DermTech, Inc. | Picozza Enrico | Director | Grant | A | 0.00 | 4,497 | 0 | 18,497 | 14 K to 18.5 K (+32.12 %) |
May 20 2021 | DMTK | DermTech, Inc. | Picozza Enrico | Director | Sell | S | 37.46 | 15,019 | 562,645 | 550,000 | 565 K to 550 K (-2.66 %) |
May 20 2021 | DMTK | DermTech, Inc. | Picozza Enrico | Director | Sell | S | 37.04 | 45,498 | 1,685,023 | 565,019 | 610.5 K to 565 K (-7.45 %) |
May 20 2021 | DMTK | DermTech, Inc. | Picozza Enrico | Director | Sell | S | 36.00 | 34,202 | 1,231,135 | 610,517 | 644.7 K to 610.5 K (-5.30 %) |
May 20 2021 | DMTK | DermTech, Inc. | Picozza Enrico | Director | Sell | S | 36.10 | 28,849 | 1,041,463 | 644,719 | 673.6 K to 644.7 K (-4.28 %) |
May 20 2021 | DMTK | DermTech, Inc. | Picozza Enrico | Director | Sell | S | 35.55 | 111,168 | 3,951,667 | 673,568 | 784.7 K to 673.6 K (-14.17 %) |
May 20 2021 | DMTK | DermTech, Inc. | Picozza Enrico | Director | Sell | S | 38.05 | 1,300 | 49,468 | 784,736 | 786 K to 784.7 K (-0.17 %) |
May 20 2021 | DMTK | DermTech, Inc. | Picozza Enrico | Director | Sell | S | 37.38 | 19,826 | 741,042 | 786,036 | 805.9 K to 786 K (-2.46 %) |
May 05 2021 | DMTK | DermTech, Inc. | Dobak John | Chief Executive Off ... | Sell | S | 42.45 | 2,171 | 92,162 | 490,116 | 492.3 K to 490.1 K (-0.44 %) |
May 05 2021 | DMTK | DermTech, Inc. | Dobak John | Chief Executive Off ... | Sell | S | 41.53 | 6,808 | 282,708 | 492,287 | 499.1 K to 492.3 K (-1.36 %) |
May 05 2021 | DMTK | DermTech, Inc. | Dobak John | Chief Executive Off ... | Sell | S | 40.51 | 16,021 | 649,060 | 499,095 | 515.1 K to 499.1 K (-3.11 %) |
Apr 21 2021 | DMTK | DermTech, Inc. | Jacobs Gary E. | Director | Option Exercise | M | 1.12 | 13,171 | 14,752 | 0 | |
Apr 21 2021 | DMTK | DermTech, Inc. | Jacobs Gary E. | Director | Option Exercise | M | 1.08 | 3,990 | 4,309 | 0 | |
Apr 21 2021 | DMTK | DermTech, Inc. | Jacobs Gary E. | Director | Option Exercise | M | 1.08 | 3,990 | 4,309 | 0 | |
Apr 21 2021 | DMTK | DermTech, Inc. | Jacobs Gary E. | Director | Option Exercise | M | 1.08 | 692 | 747 | 0 | |
Apr 21 2021 | DMTK | DermTech, Inc. | Jacobs Gary E. | Director | Buy | M | 1.12 | 13,171 | 14,752 | 547,438 | 534.3 K to 547.4 K (+2.47 %) |
Apr 21 2021 | DMTK | DermTech, Inc. | Jacobs Gary E. | Director | Buy | M | 1.08 | 3,990 | 4,309 | 534,267 | 530.3 K to 534.3 K (+0.75 %) |
Apr 21 2021 | DMTK | DermTech, Inc. | Jacobs Gary E. | Director | Buy | M | 1.08 | 3,990 | 4,309 | 530,277 | 526.3 K to 530.3 K (+0.76 %) |
Apr 21 2021 | DMTK | DermTech, Inc. | Jacobs Gary E. | Director | Buy | M | 1.08 | 692 | 747 | 526,287 | 525.6 K to 526.3 K (+0.13 %) |
Apr 14 2021 | DMTK | DermTech, Inc. | Wood Todd Michael | Chief Commercial Of ... | Sell | S | 47.80 | 488 | 23,326 | 162,944 | 163.4 K to 162.9 K (-0.30 %) |
Apr 14 2021 | DMTK | DermTech, Inc. | Wood Todd Michael | Chief Commercial Of ... | Sell | S | 46.73 | 3,919 | 183,133 | 163,432 | 167.4 K to 163.4 K (-2.34 %) |
Apr 14 2021 | DMTK | DermTech, Inc. | Wood Todd Michael | Chief Commercial Of ... | Sell | S | 45.93 | 5,593 | 256,862 | 167,351 | 172.9 K to 167.4 K (-3.23 %) |
Apr 14 2021 | DMTK | DermTech, Inc. | Dobak John | Chief Executive Off ... | Sell | S | 47.90 | 921 | 44,118 | 540,116 | 541 K to 540.1 K (-0.17 %) |
Apr 14 2021 | DMTK | DermTech, Inc. | Dobak John | Chief Executive Off ... | Sell | S | 46.79 | 9,736 | 455,534 | 541,037 | 550.8 K to 541 K (-1.77 %) |
Apr 14 2021 | DMTK | DermTech, Inc. | Dobak John | Chief Executive Off ... | Sell | S | 45.94 | 14,343 | 658,849 | 550,773 | 565.1 K to 550.8 K (-2.54 %) |
Apr 12 2021 | DMTK | DermTech, Inc. | Jacobs Gary E. | Director | Grant | A | 0.00 | 1,692 | 0 | 525,595 | 523.9 K to 525.6 K (+0.32 %) |
Apr 12 2021 | DMTK | DermTech, Inc. | Jacobs Gary E. | Director | Grant | A | 0.00 | 1,692 | 0 | 525,595 | 523.9 K to 525.6 K (+0.32 %) |
Mar 31 2021 | DMTK | DermTech, Inc. | Wood Todd Michael | Chief Commercial Of ... | Option Exercise | A | 44.48 | 12,148 | 540,343 | 12,148 | |
Mar 31 2021 | DMTK | DermTech, Inc. | Wood Todd Michael | Chief Commercial Of ... | Grant | A | 0.00 | 8,162 | 0 | 172,994 | 164.8 K to 173 K (+4.95 %) |
Mar 31 2021 | DMTK | DermTech, Inc. | Sun Kevin M | Chief Financial Off ... | Option Exercise | A | 44.48 | 11,937 | 530,958 | 11,937 | |
Mar 31 2021 | DMTK | DermTech, Inc. | Sun Kevin M | Chief Financial Off ... | Grant | A | 0.00 | 8,020 | 0 | 159,281 | 151.3 K to 159.3 K (+5.30 %) |
Mar 31 2021 | DMTK | DermTech, Inc. | Jansen Burkhard | Chief Medical Offic ... | Option Exercise | A | 44.48 | 7,289 | 324,215 | 7,289 | |
Mar 31 2021 | DMTK | DermTech, Inc. | Jansen Burkhard | Chief Medical Offic ... | Grant | A | 0.00 | 4,897 | 0 | 84,991 | 80.1 K to 85 K (+6.11 %) |
Mar 31 2021 | DMTK | DermTech, Inc. | Jansen Burkhard | Chief Medical Offic ... | Option Exercise | A | 44.48 | 7,289 | 324,215 | 7,289 | |
Mar 31 2021 | DMTK | DermTech, Inc. | Jansen Burkhard | Chief Medical Offic ... | Grant | A | 0.00 | 4,897 | 0 | 84,991 | 80.1 K to 85 K (+6.11 %) |
Mar 31 2021 | DMTK | DermTech, Inc. | Ibarra Claudia | Chief Operating Off ... | Option Exercise | A | 44.48 | 8,908 | 396,228 | 8,908 | |
Mar 31 2021 | DMTK | DermTech, Inc. | Ibarra Claudia | Chief Operating Off ... | Grant | A | 0.00 | 5,985 | 0 | 120,915 | 114.9 K to 120.9 K (+5.21 %) |
Mar 31 2021 | DMTK | DermTech, Inc. | Ibarra Claudia | Chief Operating Off ... | Option Exercise | A | 44.48 | 8,908 | 396,228 | 8,908 | |
Mar 31 2021 | DMTK | DermTech, Inc. | Ibarra Claudia | Chief Operating Off ... | Grant | A | 0.00 | 5,985 | 0 | 120,915 | 114.9 K to 120.9 K (+5.21 %) |
Mar 31 2021 | DMTK | DermTech, Inc. | Dobak John | Chief Executive Off ... | Option Exercise | A | 44.48 | 43,455 | 1,932,878 | 43,455 | |
Mar 31 2021 | DMTK | DermTech, Inc. | Dobak John | Chief Executive Off ... | Grant | A | 0.00 | 29,195 | 0 | 565,116 | 535.9 K to 565.1 K (+5.45 %) |
Mar 22 2021 | DMTK | DermTech, Inc. | Dobak John | Chief Executive Off ... | Payment of Exercise | F | 53.35 | 7,150 | 381,453 | 535,921 | 543.1 K to 535.9 K (-1.32 %) |
Mar 10 2021 | DMTK | DermTech, Inc. | Wood Todd Michael | Chief Commercial Of ... | Sell | S | 50.04 | 417 | 20,867 | 164,782 | 165.2 K to 164.8 K (-0.25 %) |
Mar 10 2021 | DMTK | DermTech, Inc. | Sun Kevin M | Chief Financial Off ... | Sell | S | 50.04 | 2,886 | 144,415 | 151,261 | 154.1 K to 151.3 K (-1.87 %) |
Mar 10 2021 | DMTK | DermTech, Inc. | Ibarra Claudia | Chief Operating Off ... | Sell | S | 50.04 | 2,431 | 121,647 | 114,930 | 117.4 K to 114.9 K (-2.07 %) |
Mar 10 2021 | DMTK | DermTech, Inc. | Dobak John | Chief Executive Off ... | Sell | S | 50.04 | 780 | 39,031 | 543,071 | 543.9 K to 543.1 K (-0.14 %) |
Jan 28 2021 | DMTK | DermTech, Inc. | Jansen Burkhard | Chief Medical Offic ... | Option Exercise | M | 6.94 | 5,000 | 34,700 | 16,244 | |
Jan 28 2021 | DMTK | DermTech, Inc. | Jansen Burkhard | Chief Medical Offic ... | Buy | M | 6.94 | 5,000 | 34,700 | 79,037 | 74 K to 79 K (+6.75 %) |
Jan 13 2021 | DMTK | DermTech, Inc. | Posard Matthew L. | Director | Buy | P | 29.50 | 33,898 | 999,991 | 86,863 | 53 K to 86.9 K (+64.00 %) |
Jan 11 2021 | DMTK | DermTech, Inc. | RTW INVESTMENTS, LP | 10% Owner | Buy | P | 29.50 | 200,000 | 5,900,000 | 3,087,216 | 2.9 M to 3.1 M (+6.93 %) |
Dec 17 2020 | DMTK | DermTech, Inc. | Jansen Burkhard | Chief Medical Offic ... | Sell | S | 12.20 | 5,000 | 61,000 | 74,037 | 79 K to 74 K (-6.33 %) |
Dec 16 2020 | DMTK | DermTech, Inc. | PANCOAST SCOTT R | Director | Sell | S | 13.93 | 6,000 | 83,569 | 44,132 | 50.1 K to 44.1 K (-11.97 %) |
Dec 16 2020 | DMTK | DermTech, Inc. | Jansen Burkhard | Chief Medical Offic ... | Sell | S | 12.41 | 5,000 | 62,050 | 79,037 | 84 K to 79 K (-5.95 %) |
Dec 10 2020 | DMTK | DermTech, Inc. | Wood Todd Michael | Chief Commercial Of ... | Sell | S | 11.86 | 428 | 5,076 | 165,199 | 165.6 K to 165.2 K (-0.26 %) |
Dec 10 2020 | DMTK | DermTech, Inc. | Ibarra Claudia | Chief Operating Off ... | Sell | S | 11.86 | 2,421 | 28,713 | 115,246 | 117.7 K to 115.2 K (-2.06 %) |
Dec 10 2020 | DMTK | DermTech, Inc. | Dobak John | Chief Executive Off ... | Sell | S | 11.86 | 786 | 9,322 | 541,683 | 542.5 K to 541.7 K (-0.14 %) |
Dec 09 2020 | DMTK | DermTech, Inc. | PANCOAST SCOTT R | Director | Sell | S | 12.00 | 2,382 | 28,584 | 50,132 | 52.5 K to 50.1 K (-4.54 %) |
Dec 09 2020 | DMTK | DermTech, Inc. | PANCOAST SCOTT R | Director | Sell | S | 12.00 | 2,382 | 28,584 | 50,132 | 52.5 K to 50.1 K (-4.54 %) |
Oct 28 2020 | DMTK | DermTech, Inc. | Jacobs Gary E. | Director | Option Exercise | M | 1.08 | 692 | 747 | 0 | |
Oct 28 2020 | DMTK | DermTech, Inc. | Jacobs Gary E. | Director | Buy | M | 1.08 | 692 | 747 | 523,903 | 523.2 K to 523.9 K (+0.13 %) |
Sep 14 2020 | DMTK | DermTech, Inc. | Wood Todd Michael | Chief Commercial Of ... | Sell | S | 11.25 | 495 | 5,569 | 165,627 | 166.1 K to 165.6 K (-0.30 %) |
Sep 14 2020 | DMTK | DermTech, Inc. | Wood Todd Michael | Chief Commercial Of ... | Sell | S | 10.57 | 850 | 8,989 | 166,122 | 167 K to 166.1 K (-0.51 %) |
Sep 14 2020 | DMTK | DermTech, Inc. | Dobak John | Chief Executive Off ... | Sell | S | 11.25 | 910 | 10,238 | 542,469 | 543.4 K to 542.5 K (-0.17 %) |
Sep 14 2020 | DMTK | DermTech, Inc. | Dobak John | Chief Executive Off ... | Sell | S | 10.57 | 1,560 | 16,497 | 543,379 | 544.9 K to 543.4 K (-0.29 %) |
Sep 14 2020 | DMTK | DermTech, Inc. | Ibarra Claudia | Chief Operating Off ... | Sell | S | 11.25 | 2,803 | 31,535 | 117,667 | 120.5 K to 117.7 K (-2.33 %) |
Sep 14 2020 | DMTK | DermTech, Inc. | Ibarra Claudia | Chief Operating Off ... | Sell | S | 10.57 | 4,802 | 50,781 | 120,470 | 125.3 K to 120.5 K (-3.83 %) |
Aug 19 2020 | DMTK | DermTech, Inc. | RTW INVESTMENTS, LP | 10% Owner | Option Exercise | X | 9.54 | 31,450 | 300,033 | 31,450 | |
Aug 19 2020 | DMTK | DermTech, Inc. | RTW INVESTMENTS, LP | 10% Owner | Buy | X | 9.54 | 31,450 | 300,033 | 2,887,216 | 2.9 M to 2.9 M (+1.10 %) |
Jun 26 2020 | DMTK | DermTech, Inc. | Yao Zuxu | Chief Scientific Of ... | Option Exercise | A | 14.88 | 23,439 | 348,772 | 23,439 | |
Jun 26 2020 | DMTK | DermTech, Inc. | Yao Zuxu | Chief Scientific Of ... | Grant | A | 0.00 | 13,317 | 0 | 84,364 | 71 K to 84.4 K (+18.74 %) |
Jun 26 2020 | DMTK | DermTech, Inc. | Yao Zuxu | Chief Scientific Of ... | Option Exercise | A | 14.88 | 23,439 | 348,772 | 23,439 | |
Jun 26 2020 | DMTK | DermTech, Inc. | Yao Zuxu | Chief Scientific Of ... | Grant | A | 0.00 | 13,317 | 0 | 84,364 | 71 K to 84.4 K (+18.74 %) |
Jun 26 2020 | DMTK | DermTech, Inc. | Wood Todd Michael | Chief Commercial Of ... | Option Exercise | A | 14.88 | 28,077 | 417,786 | 28,077 | |
Jun 26 2020 | DMTK | DermTech, Inc. | Wood Todd Michael | Chief Commercial Of ... | Grant | A | 0.00 | 15,952 | 0 | 166,972 | 151 K to 167 K (+10.56 %) |
Jun 26 2020 | DMTK | DermTech, Inc. | Sun Kevin M | Chief Financial Off ... | Option Exercise | A | 14.88 | 35,108 | 522,407 | 35,108 | |
Jun 26 2020 | DMTK | DermTech, Inc. | Sun Kevin M | Chief Financial Off ... | Grant | A | 0.00 | 19,947 | 0 | 151,979 | 132 K to 152 K (+15.11 %) |
Jun 26 2020 | DMTK | DermTech, Inc. | Jansen Burkhard | Chief Medical Offic ... | Option Exercise | A | 14.88 | 22,655 | 337,106 | 22,655 | |
Jun 26 2020 | DMTK | DermTech, Inc. | Jansen Burkhard | Chief Medical Offic ... | Grant | A | 0.00 | 12,872 | 0 | 84,037 | 71.2 K to 84 K (+18.09 %) |
Jun 26 2020 | DMTK | DermTech, Inc. | Ibarra Claudia | Chief Operating Off ... | Option Exercise | A | 14.88 | 25,780 | 383,606 | 25,780 | |
Jun 26 2020 | DMTK | DermTech, Inc. | Ibarra Claudia | Chief Operating Off ... | Grant | A | 0.00 | 14,647 | 0 | 125,272 | 110.6 K to 125.3 K (+13.24 %) |
Jun 26 2020 | DMTK | DermTech, Inc. | Dobak John | Chief Executive Off ... | Option Exercise | A | 14.90 | 107,215 | 1,597,504 | 107,215 | |
Jun 26 2020 | DMTK | DermTech, Inc. | Dobak John | Chief Executive Off ... | Grant | A | 0.00 | 60,916 | 0 | 544,939 | 484 K to 544.9 K (+12.59 %) |
Jun 19 2020 | DMTK | DermTech, Inc. | ROSENMAN HERM | Director | Grant | A | 0.00 | 8,000 | 0 | 43,224 | 35.2 K to 43.2 K (+22.71 %) |
Jun 19 2020 | DMTK | DermTech, Inc. | Posard Matthew L. | Director | Grant | A | 0.00 | 8,000 | 0 | 52,965 | 45 K to 53 K (+17.79 %) |
Jun 19 2020 | DMTK | DermTech, Inc. | Picozza Enrico | Director | Grant | A | 0.00 | 8,000 | 0 | 14,000 | 6 K to 14 K (+133.33 %) |
Jun 19 2020 | DMTK | DermTech, Inc. | PANCOAST SCOTT R | Director | Grant | A | 0.00 | 8,000 | 0 | 52,514 | 44.5 K to 52.5 K (+17.97 %) |
Jun 19 2020 | DMTK | DermTech, Inc. | Collins Cynthia | Director | Grant | A | 0.00 | 8,000 | 0 | 33,483 | 25.5 K to 33.5 K (+31.39 %) |
May 29 2020 | DMTK | DermTech, Inc. | Picozza Enrico | Director | Option Exercise | P | 0.00 | 114 | 0 | 114 | |
May 29 2020 | DMTK | DermTech, Inc. | Picozza Enrico | Director | Buy | P | 10.50 | 76,228 | 800,394 | 691,613 | 615.4 K to 691.6 K (+12.39 %) |
May 29 2020 | DMTK | DermTech, Inc. | RTW INVESTMENTS, LP | 10% Owner | Option Exercise | C | 0.00 | 228 | 0 | 0 | |
May 29 2020 | DMTK | DermTech, Inc. | RTW INVESTMENTS, LP | 10% Owner | Buy | C | 0.00 | 228,498 | 0 | 2,855,766 | 2.6 M to 2.9 M (+8.70 %) |
May 13 2020 | DMTK | DermTech, Inc. | Irwin & Joan Jacobs Trust Date ... | 10% Owner | Option Exercise | X | 9.54 | 41,932 | 400,031 | 0 | |
May 13 2020 | DMTK | DermTech, Inc. | Irwin & Joan Jacobs Trust Date ... | 10% Owner | Buy | X | 9.54 | 41,932 | 400,031 | 1,808,434 | 1.8 M to 1.8 M (+2.37 %) |
May 01 2020 | DMTK | DermTech, Inc. | Posard Matthew L. | Director | Option Exercise | M | 6.94 | 9,702 | 67,332 | 0 | |
May 01 2020 | DMTK | DermTech, Inc. | Posard Matthew L. | Director | Buy | M | 6.94 | 9,702 | 67,332 | 44,965 | 35.3 K to 45 K (+27.51 %) |
Apr 01 2020 | DMTK | DermTech, Inc. | RTW INVESTMENTS, LP | 10% Owner | Buy | P | 10.41 | 26,539 | 276,316 | 2,627,268 | 2.6 M to 2.6 M (+1.02 %) |
Apr 01 2020 | DMTK | DermTech, Inc. | RTW INVESTMENTS, LP | 10% Owner | Buy | P | 11.26 | 5,000 | 56,321 | 2,600,729 | 2.6 M to 2.6 M (+0.19 %) |
Mar 20 2020 | DMTK | DermTech, Inc. | Dobak John | Chief Executive Off ... | Grant | A | 0.00 | 17,842 | 0 | 484,023 | 466.2 K to 484 K (+3.83 %) |
Mar 05 2020 | CNACU | DermTech, Inc. | RTW INVESTMENTS, LP | 10% Owner | Buy | P | 14.61 | 23,955 | 350,088 | 2,595,729 | 2.6 M to 2.6 M (+0.93 %) |
Mar 05 2020 | CNACU | DermTech, Inc. | RTW INVESTMENTS, LP | 10% Owner | Buy | P | 14.75 | 4,447 | 65,593 | 2,571,774 | 2.6 M to 2.6 M (+0.17 %) |
Mar 05 2020 | CNACU | DermTech, Inc. | RTW INVESTMENTS, LP | 10% Owner | Buy | P | 14.52 | 13,000 | 188,713 | 2,567,327 | 2.6 M to 2.6 M (+0.51 %) |
Mar 04 2020 | CNACU | DermTech, Inc. | PANCOAST SCOTT R | Director | Option Exercise | M | 1.12 | 10,640 | 11,917 | 2,833 | |
Mar 04 2020 | CNACU | DermTech, Inc. | PANCOAST SCOTT R | Director | Buy | M | 1.12 | 10,640 | 11,917 | 44,514 | 33.9 K to 44.5 K (+31.41 %) |
Mar 03 2020 | CNACU | DermTech, Inc. | RTW INVESTMENTS, LP | 10% Owner | Option Exercise | P | 0.00 | 228 | 0 | 228 | |
Mar 03 2020 | CNACU | DermTech, Inc. | RTW INVESTMENTS, LP | 10% Owner | Buy | P | 12.83 | 15,000 | 192,428 | 2,554,327 | 2.5 M to 2.6 M (+0.59 %) |
Mar 03 2020 | CNACU | DermTech, Inc. | RTW INVESTMENTS, LP | 10% Owner | Buy | P | 10.50 | 152,456 | 1,600,788 | 2,539,327 | 2.4 M to 2.5 M (+6.39 %) |
Feb 11 2020 | CNACU | DermTech, Inc. | PANCOAST SCOTT R | Director | Option Exercise | M | 1.08 | 3,990 | 4,309 | 0 | |
Feb 11 2020 | CNACU | DermTech, Inc. | PANCOAST SCOTT R | Director | Buy | M | 1.08 | 3,990 | 4,309 | 33,874 | 29.9 K to 33.9 K (+13.35 %) |
Feb 07 2020 | CNACU | DermTech, Inc. | PANCOAST SCOTT R | Director | Option Exercise | M | 1.08 | 3,990 | 4,309 | 0 | |
Feb 07 2020 | CNACU | DermTech, Inc. | PANCOAST SCOTT R | Director | Buy | M | 1.08 | 3,990 | 4,309 | 29,884 | 25.9 K to 29.9 K (+15.41 %) |
Feb 03 2020 | CNACU | DermTech, Inc. | ROSENMAN HERM | Director | Grant | A | 0.00 | 6,000 | 0 | 35,224 | 29.2 K to 35.2 K (+20.53 %) |
Feb 03 2020 | CNACU | DermTech, Inc. | Picozza Enrico | Director | Grant | A | 0.00 | 6,000 | 0 | 6,000 | 0 to 6 K |
Feb 03 2020 | CNACU | DermTech, Inc. | PANCOAST SCOTT R | Director | Grant | A | 0.00 | 6,000 | 0 | 25,894 | 19.9 K to 25.9 K (+30.16 %) |
Feb 03 2020 | CNACU | DermTech, Inc. | Jacobs Gary E. | Director | Grant | A | 0.00 | 6,000 | 0 | 515,211 | 509.2 K to 515.2 K (+1.18 %) |
Feb 03 2020 | CNACU | DermTech, Inc. | Collins Cynthia | Director | Grant | A | 0.00 | 6,000 | 0 | 25,483 | 19.5 K to 25.5 K (+30.80 %) |
Jan 22 2020 | CNACU | DermTech, Inc. | Sun Kevin M | Chief Financial Off ... | Grant | A | 0.00 | 132,032 | 0 | 132,032 | 0 to 132 K |
Jan 22 2020 | CNACU | DermTech, Inc. | Dobak John | Chief Executive Off ... | Grant | A | 0.00 | 26,901 | 0 | 466,181 | 439.3 K to 466.2 K (+6.12 %) |
Jan 22 2020 | CNACU | DermTech, Inc. | Wood Todd Michael | Chief Commercial Of ... | Grant | A | 0.00 | 14,647 | 0 | 151,020 | 136.4 K to 151 K (+10.74 %) |
Jan 16 2020 | CNACU | DermTech, Inc. | Yao Zuxu | Chief Scientific Of ... | Option Exercise | A | 9.73 | 43,854 | 426,699 | 43,854 | |
Jan 16 2020 | CNACU | DermTech, Inc. | Wood Todd Michael | Chief Commerical Of ... | Option Exercise | A | 9.73 | 22,535 | 219,266 | 22,535 | |
Jan 16 2020 | CNACU | DermTech, Inc. | Sun Kevin M | CFO | Option Exercise | A | 9.73 | 30,983 | 301,465 | 30,893 | |
Jan 16 2020 | CNACU | DermTech, Inc. | Jansen Burkhard | Chief Medical Offic ... | Option Exercise | A | 9.73 | 43,120 | 419,558 | 43,120 | |
Jan 16 2020 | CNACU | DermTech, Inc. | Dobak John | Chief Executive Off ... | Option Exercise | A | 9.73 | 76,861 | 747,858 | 76,861 | |
Jan 03 2020 | CNACU | DermTech, Inc. | ROSENMAN HERM | Director | Option Exercise | M | 0.00 | 17,703 | 0 | 0 | |
Jan 03 2020 | CNACU | DermTech, Inc. | ROSENMAN HERM | Director | Buy | M | 0.00 | 17,703 | 0 | 29,224 | 11.5 K to 29.2 K (+153.66 %) |
Jan 03 2020 | CNACU | DermTech, Inc. | Salkind Gene | Director | Option Exercise | M | 0.00 | 7,593 | 0 | 0 | |
Jan 03 2020 | CNACU | DermTech, Inc. | Salkind Gene | Director | Buy | M | 0.00 | 7,593 | 0 | 173,154 | 165.6 K to 173.2 K (+4.59 %) |
Jan 03 2020 | CNACU | DermTech, Inc. | PANCOAST SCOTT R | Director | Option Exercise | M | 0.00 | 17,512 | 0 | 0 | |
Jan 03 2020 | CNACU | DermTech, Inc. | PANCOAST SCOTT R | Director | Buy | M | 0.00 | 17,512 | 0 | 19,894 | 2.4 K to 19.9 K (+735.18 %) |
Jan 03 2020 | CNACU | DermTech, Inc. | Dobak John | Chief Executive Off ... | Option Exercise | M | 0.00 | 155,720 | 0 | 0 | |
Jan 03 2020 | CNACU | DermTech, Inc. | Dobak John | Chief Executive Off ... | Payment of Exercise | F | 12.40 | 59,558 | 738,519 | 439,280 | 498.8 K to 439.3 K (-11.94 %) |
Jan 03 2020 | CNACU | DermTech, Inc. | Dobak John | Chief Executive Off ... | Buy | M | 0.00 | 155,720 | 0 | 498,838 | 343.1 K to 498.8 K (+45.38 %) |
Jan 03 2020 | CNACU | DermTech, Inc. | Collins Cynthia | Director | Option Exercise | M | 0.00 | 8,755 | 0 | 0 | |
Jan 03 2020 | CNACU | DermTech, Inc. | Collins Cynthia | Director | Buy | M | 0.00 | 8,755 | 0 | 19,483 | 10.7 K to 19.5 K (+81.61 %) |
Oct 17 2019 | CNACU | DermTech, Inc. | COWEN INC. | 10% Owner | Sell | S | 10.40 | 100 | 1,040 | 622,762 | 622.9 K to 622.8 K (-0.02 %) |
Oct 17 2019 | CNACU | DermTech, Inc. | COWEN INC. | 10% Owner | Sell | S | 10.36 | 100 | 1,036 | 622,862 | 623 K to 622.9 K (-0.02 %) |
Oct 17 2019 | CNACU | DermTech, Inc. | COWEN INC. | 10% Owner | Sell | S | 10.34 | 100 | 1,034 | 622,962 | 623.1 K to 623 K (-0.02 %) |
Oct 17 2019 | CNACU | DermTech, Inc. | COWEN INC. | 10% Owner | Buy | P | 10.40 | 100 | 1,040 | 623,062 | 623 K to 623.1 K (+0.02 %) |
Oct 17 2019 | CNACU | DermTech, Inc. | COWEN INC. | 10% Owner | Buy | P | 10.38 | 200 | 2,076 | 622,962 | 622.8 K to 623 K (+0.03 %) |
Oct 17 2019 | CNACU | DermTech, Inc. | COWEN INC. | 10% Owner | Buy | P | 10.39 | 100 | 1,039 | 622,762 | 622.7 K to 622.8 K (+0.02 %) |
Oct 17 2019 | CNACU | DermTech, Inc. | COWEN INC. | 10% Owner | Buy | P | 10.35 | 1,000 | 10,350 | 622,662 | 621.7 K to 622.7 K (+0.16 %) |
Oct 17 2019 | CNACU | DermTech, Inc. | COWEN INC. | 10% Owner | Buy | P | 10.34 | 1,500 | 15,510 | 621,662 | 620.2 K to 621.7 K (+0.24 %) |
Oct 17 2019 | CNACU | DermTech, Inc. | COWEN INC. | 10% Owner | Buy | P | 10.34 | 100 | 1,034 | 620,162 | 620.1 K to 620.2 K (+0.02 %) |
Oct 17 2019 | CNACU | DermTech, Inc. | COWEN INC. | 10% Owner | Buy | P | 10.34 | 300 | 3,102 | 620,062 | 619.8 K to 620.1 K (+0.05 %) |
Oct 17 2019 | CNACU | DermTech, Inc. | COWEN INC. | 10% Owner | Buy | P | 10.30 | 6,836 | 70,411 | 619,762 | 612.9 K to 619.8 K (+1.12 %) |
Oct 17 2019 | CNACU | DermTech, Inc. | COWEN INC. | 10% Owner | Buy | P | 10.29 | 1,726 | 17,761 | 612,926 | 611.2 K to 612.9 K (+0.28 %) |
Oct 17 2019 | CNACU | DermTech, Inc. | COWEN INC. | 10% Owner | Buy | P | 10.25 | 400 | 4,098 | 611,200 | 610.8 K to 611.2 K (+0.07 %) |
Oct 17 2019 | CNACU | DermTech, Inc. | COWEN INC. | 10% Owner | Buy | P | 10.32 | 100 | 1,032 | 610,800 | 610.7 K to 610.8 K (+0.02 %) |